Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact
Open accessThe DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Abstract
The picture of chronic liver diseases (CLDs) has changed considerably in recent years. One of them is the increase of non-alcoholic fatty liver disease. More and more CLD patients, even those with liver cirrhosis (LC), tend to be presenting with obesity these days. The annual rate of muscle loss increases with worsening liver reserve, and thus LC patients are more likely to complicate with sarcopenia. LC is also characterized by protein-energy malnutrition (PEM). Since the PEM in LC can be invariable, the patients probably present with sarcopenic obesity (Sa-O), which involves both sarcopenia and obesity. Currently, there is no mention of Sa-O in the guidelines; however, the rapidly increasing prevalence and poorer clinical consequences of Sa-O are recognized as an important public health problem, and the diagnostic value of Sa-O is expected to increase in the future. Sa-O involves a complex interplay of physiological mechanisms, including increased inflammatory cytokines, oxidative stress, insulin resistance, hormonal disorders, and decline of physical activity. The pathogenesis of Sa-O in LC is diverse, with a lot of perturbations in the muscle–liver–adipose tissue axis. Here, we overview the current knowledge of Sa-O, especially focusing on LC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, there are no internationally standardized criteria for diagnosing SO [22].”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [22]
In the citing paper
“As mentioned earlier, physical inactivity and obesity increase the level of lipid circulation and myosteatosis in skeletal muscle, contributing to a decrease in muscle mass and strength and favoring sarcopenia and physical disabilities [14, 22, 66].”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment
Chen, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Chou, M.-Y., Iijima, K., Jang, H. C., Kang, L., Kim, M., Kim, S., et al. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.12.012 · Cited by 7,070 · cited 2×
“Primary sarcopenia is defined as a condition in which SMM and muscle strength or physical function decline with aging, while secondary sarcopenia is defined as a condition in which SMM and muscle strength or physical function are impaired due to underlying diseases [3,4].”
BackgroundSarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Inflammatory Mechanisms in Obesity
Gregor, M. F., & Hotamisligil, G. S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101322 · Cited by 3,754 · cited 1×
“In contrast, increase of a visceral fat induces inflammation, contributing to the sarcopenia incidence [49].”
BackgroundAlterations of the human gut microbiome in liver cirrhosis
Qin, N., Yang, F., Li, A., Prifti, E., Chen, Y., Shao, L., Guo, J., Le Chatelier, E., Yao, J., Wu, L., et al. (2014) · Nature · doi:10.1038/nature13568 · Cited by 2,177
Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention
Liu, R., Hong, J., Xu, X., Feng, Q., Zhang, D., Gu, Y., Shi, J., Zhao, S., Liu, W., Wang, X., et al. (2017) · Nature Medicine · doi:10.1038/nm.4358 · Cited by 1,501
Long-term health benefits of physical activity – a systematic review of longitudinal studies
Reiner, M., Niermann, C., Jekauc, D., & Woll, A. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-813 · Cited by 1,447
Liver inflammation and fibrosis
Koyama, Y., & Brenner, D. A. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88881 · Cited by 1,295 · cited 1×
“LC patients are likely to be involved in insulin resistance and chronic inflammation [38].”
BackgroundRosenberg, I. H. (1989) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/50.5.1231 · Cited by 1,102
Altered profile of human gut microbiome is associated with cirrhosis and its complications
Bajaj, J. S., Heuman, D. M., Hylemon, P. B., Sanyal, A. J., White, M. B., Monteith, P., Noble, N. A., Unser, A. B., Daita, K., Fisher, A. R., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.019 · Cited by 1,099 · cited 1×
“Dysbiosis in LC can lead to (a) reduced bacterial diversity [76,77], (b) reduced short chain fatty acid [78], (c) tight junction failure and increased intestinal permeability [79], (d) decreased antioxidant effect [80], and (e) endotoxemia [81,82].”
BackgroundWeight loss, exercise, or both and physical function in obese older adults
Villareal, D. T., Chode, S., Parimi, N., Sinacore, D. R., Hilton, T., Armamento-Villareal, R., Napoli, N., Qualls, C., & Shah, K. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008234 · Cited by 1,096 · cited 1×
“This combination therapy results in a benefit to physical function, even in patients without an increase in muscle mass [90].”
BackgroundBody Composition in Healthy Aging
BAUMGARTNER, R. N. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06498.x · Cited by 1,078 · cited 2×
“Sa-O involves a complex interplay of physiological mechanisms, including increased inflammatory cytokines, oxidative stress, insulin resistance, hormonal disorders, and decline of physical activity [10,11,18,19].”
BackgroundLi, J., Zou, B., Yeo, Y. H., Feng, Y., Xie, X., Lee, D. H., Fujii, H., Wu, Y., Kam, L. Y., Ji, F., et al. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30039-1 · Cited by 1,031
Sarcopenic obesity: A new category of obesity in the elderly
Zamboni, M., Mazzali, G., Fantin, F., Rossi, A., & Di Francesco, V. (2008) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.10.002 · Cited by 953 · cited 2×
“Sa-O involves a complex interplay of physiological mechanisms, including increased inflammatory cytokines, oxidative stress, insulin resistance, hormonal disorders, and decline of physical activity [10,11,18,19].”
BackgroundShintani, Y., Fujie, H., Miyoshi, H., Tsutsumi, T., Tsukamoto, K., Kimura, S., Moriya, K., & Koike, K. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.056 · Cited by 763
ESPEN Guidelines on Enteral Nutrition: Liver disease
Plauth, M., Cabré, E., Riggio, O., Assis-Camilo, M., Pirlich, M., Kondrup, J., Ferenci, P., Holm, E., vom Dahl, S., Müller, M. J., et al. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2006.01.018 · Cited by 688
Nishikawa, H., Shiraki, M., Hiramatsu, A., Moriya, K., Hino, K., & Nishiguchi, S. (2016) · Hepatology Research · doi:10.1111/hepr.12774 · Cited by 656
Self-citationInsulin resistance and sarcopenia: mechanistic links between common co-morbidities
Cleasby, M. E., Jamieson, P. M., & Atherton, P. J. (2016) · Journal of Endocrinology · doi:10.1530/joe-15-0533 · Cited by 596
Rosenberg, I. H. (1989) · American Journal of Clinical Nutrition · Cited by 589
Villareal, D. T., Apovian, C. M., Kushner, R. F., & Klein, S. (2005) · Obesity Research · doi:10.1038/oby.2005.228 · Cited by 579
Montano-Loza, A. J., Angulo, P., Meza-Junco, J., Prado, C. M. M., Sawyer, M. B., Beaumont, C., Esfandiari, N., Ma, M., & Baracos, V. E. (2016) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12039 · Cited by 512 · cited 3×
“5-to 2-fold, mainly due to the higher incidence of sepsis-related death [20].”
BackgroundInfluentialCorrea-de-Araujo, R., Addison, O., Miljkovic, I., Goodpaster, B. H., Bergman, B. C., Clark, R. V., Elena, J. W., Esser, K. A., Ferrucci, L., Harris-Love, M. O., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00963 · Cited by 468
Amodio, P., Bemeur, C., Butterworth, R., Cordoba, J., Kato, A., Montagnese, S., Uribe, M., Vilstrup, H., & Morgan, M. Y. (2013) · Hepatology · doi:10.1002/hep.26370 · Cited by 420
Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity
Wannamethee, S. G., & Atkins, J. L. (2015) · Proceedings of the Nutrition Society · doi:10.1017/s002966511500169x · Cited by 404
Guo, T., Jou, W., Chanturiya, T., Portas, J., Gavrilova, O., & McPherron, A. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004937 · Cited by 402 · cited 1×
“Serum myostatin levels can be lowered by aerobic exercise [58].”
BackgroundImaging of sarcopenia: old evidence and new insights
Albano, D., Messina, C., Vitale, J., & Sconfienza, L. M. (2020) · European Radiology · doi:10.1007/s00330-019-06573-2 · Cited by 400
Cheung, K., Lee, S. S., & Raman, M. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.08.016 · Cited by 343
Imajo, K., Fujita, K., Yoneda, M., Nozaki, Y., Ogawa, Y., Shinohara, Y., Kato, S., Mawatari, H., Shibata, W., Kitani, H., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.05.012 · Cited by 341 · cited 1×
“In obesity-associated fatty liver, leptin induces CD14 expression via activation of STAT3 signaling in Kupffer cells, leading to marked inflammation and fibrosis by increasing the responsiveness of the liver to low dose of endotoxin [48].”
BackgroundLee, Y., Kim, S. U., Song, K., Park, J. Y., Kim, D. Y., Ahn, S. H., Lee, B., Kang, E. S., Cha, B., & Han, K. (2016) · Hepatology · doi:10.1002/hep.28376 · Cited by 340
Branched-chain amino acids as pharmacological nutrients in chronic liver disease
Kawaguchi, T., Izumi, N., Charlton, M. R., & Sata, M. (2011) · Hepatology · doi:10.1002/hep.24412 · Cited by 331
Increased secretion and expression of myostatin in skeletal muscle from extremely obese women
Hittel, D. S., Berggren, J. R., Shearer, J., Boyle, K., & Houmard, J. A. (2009) · Diabetes · doi:10.2337/db08-0943 · Cited by 324 · cited 2×
“reported that extremely obese individuals have been reported to have a 35% increase in plasma mature myostatin level and a 23% increase in skeletal muscle precursor myostatin level, as compared to lean controls, and BMI strongly correlated with myostatin level in skeletal muscle [56].”
BackgroundQiu, J., Thapaliya, S., Runkana, A., Yang, Y., Tsien, C., Mohan, M. L., Narayanan, A., Eghtesad, B., Mozdziak, P. E., McDonald, C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317049110 · Cited by 292
Sinclair, M., Grossmann, M., Hoermann, R., Angus, P. W., & Gow, P. J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.06.007 · Cited by 269 · cited 2×
“A previous randomized trial emphasized the significance of testosterone supplementation therapy on the improvement of SMM in male LC patients [40].”
BackgroundConsilience in sarcopenia of cirrhosis
Dasarathy, S. (2012) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-012-0069-3 · Cited by 247
Zenith, L., Meena, N., Ramadi, A., Yavari, M., Harvey, A., Carbonneau, M., Ma, M., Abraldes, J. G., Paterson, I., Haykowsky, M. J., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.04.016 · Cited by 240
Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis
Kumar, A., Davuluri, G., Silva, R. N. E., Engelen, M. P. K. J., Ten Have, G. A. M., Prayson, R., Deutz, N. E. P., & Dasarathy, S. (2017) · Hepatology · doi:10.1002/hep.29107 · Cited by 235
Miljkovic, I., & Zmuda, J. M. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328337d826 · Cited by 234
Oxidative stress and disuse muscle atrophy: cause or consequence?
Powers, S. K., Smuder, A. J., & Judge, A. R. (2012) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328352b4c2 · Cited by 233
The implications of sarcopenia and sarcopenic obesity on cardiometabolic disease
Kim, T. N., & Choi, K. M. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25077 · Cited by 225 · cited 2×
“Sa-O involves a complex interplay of physiological mechanisms, including increased inflammatory cytokines, oxidative stress, insulin resistance, hormonal disorders, and decline of physical activity [10,11,18,19].”
BackgroundDuarte‐Rojo, A., Ruiz‐Margáin, A., Montaño‐Loza, A. J., Macías‐Rodríguez, R. U., Ferrando, A., & Kim, W. R. (2018) · Liver Transplantation · doi:10.1002/lt.24958 · Cited by 221
MUTO, Y., SATO, S., WATANABE, A., MORIWAKI, H., SUZUKI, K., KATO, A., KATO, M., NAKAMURA, T., HIGUCHI, K., & NISHIGUCHI, S. (2006) · Hepatology Research · doi:10.1016/j.hepres.2006.04.007 · Cited by 216
Self-citationPetta, S., Ciminnisi, S., Di Marco, V., Cabibi, D., Cammà, C., Licata, A., Marchesini, G., & Craxì, A. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13889 · Cited by 215
Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis
Bhanji, R. A., Moctezuma-Velazquez, C., Duarte-Rojo, A., Ebadi, M., Ghosh, S., Rose, C., & Montano-Loza, A. J. (2018) · Hepatology International · doi:10.1007/s12072-018-9875-9 · Cited by 210
Branched-chain amino acids as a protein- and energy-source in liver cirrhosis
Moriwaki, H., Miwa, Y., Tajika, M., Kato, M., Fukushima, H., & Shiraki, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.07.016 · Cited by 199
Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis
Nishikawa, H., Enomoto, H., Ishii, A., Iwata, Y., Miyamoto, Y., Ishii, N., Yuri, Y., Hasegawa, K., Nakano, C., Nishimura, T., et al. (2017) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12212 · Cited by 196
Self-citationCritical role of PA28γ in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis
Moriishi, K., Mochizuki, R., Moriya, K., Miyamoto, H., Mori, Y., Abe, T., Murata, S., Tanaka, K., Miyamura, T., Suzuki, T., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607312104 · Cited by 194
Sarcopenic obesity and endocrinal adaptation with age
Sakuma, K., & Yamaguchi, A. (2013) · International Journal of Endocrinology · doi:10.1155/2013/204164 · Cited by 189
Rapid skeletal muscle wasting predicts worse survival in patients with liver cirrhosis
Hanai, T., Shiraki, M., Ohnishi, S., Miyazaki, T., Ideta, T., Kochi, T., Imai, K., Suetsugu, A., Takai, K., Moriwaki, H., et al. (2016) · Hepatology Research · doi:10.1111/hepr.12616 · Cited by 186
What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?
Finelli, C. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i6.802 · Cited by 183
Gut dysbiosis associated with hepatitis C virus infection
Inoue, T., Nakayama, J., Moriya, K., Kawaratani, H., Momoda, R., Ito, K., Iio, E., Nojiri, S., Fujiwara, K., Yoneda, M., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy205 · Cited by 183
Nagpal, R., Newman, T. M., Wang, S., Jain, S., Lovato, J. F., & Yadav, H. (2018) · Journal of Diabetes Research · doi:10.1155/2018/3462092 · Cited by 177
Kobayashi, A., Kaido, T., Hamaguchi, Y., Okumura, S., Shirai, H., Yao, S., Kamo, N., Yagi, S., Taura, K., Okajima, H., et al. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000002555 · Cited by 168
Streba, L. A. M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i14.4103 · Cited by 161
Román, E., García-Galcerán, C., Torrades, T., Herrera, S., Marín, A., Doñate, M., Alvarado-Tapias, E., Malouf, J., Nácher, L., Serra-Grima, R., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0151652 · Cited by 157
Reinders, I., Murphy, R. A., Brouwer, I. A., Visser, M., Launer, L., Siggeirsdottir, K., Eiriksdottir, G., Gudnason, V., Jonsson, P. V., Lang, T. F., et al. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kwv153 · Cited by 155
Macías-Rodríguez, R. U., Ilarraza-Lomelí, H., Ruiz-Margáin, A., Ponce-de-León-Rosales, S., Vargas-Vorácková, F., García-Flores, O., Torre, A., & Duarte-Rojo, A. (2016) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2016.38 · Cited by 142
Kim, T. N., Park, M. S., Ryu, J. Y., Choi, H. Y., Hong, H. C., Yoo, H. J., Kang, H. J., Song, W., Park, S. W., Baik, S. H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115407 · Cited by 133 · cited 1×
“reported, in a longitudinal study, that visceral obesity was associated with future SMM decline in Korean individuals [50].”
Carias, S., Castellanos, A. L., Vilchez, V., Nair, R., Dela Cruz, A. C., Watkins, J., Barrett, T., Trushar, P., Esser, K., & Gedaly, R. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13166 · Cited by 130
Home Exercise Training Improves Exercise Capacity in Cirrhosis Patients: Role of Exercise Adherence
Kruger, C., McNeely, M. L., Bailey, R. J., Yavari, M., Abraldes, J. G., Carbonneau, M., Newnham, K., DenHeyer, V., Ma, M., Thompson, R., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-18320-y · Cited by 130
Myosteatosis and myofibrosis: Relationship with aging, inflammation and insulin resistance
Zoico, E., Corzato, F., Bambace, C., Rossi, A. P., Micciolo, R., Cinti, S., Harris, T. B., & Zamboni, M. (2013) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2013.06.001 · Cited by 118
El-Swefy, S. E., Abdallah, F. R., Atteia, H. H., Wahba, A. S., & Hasan, R. A. (2016) · International Journal of Experimental Pathology · doi:10.1111/iep.12207 · Cited by 115
Hara, N., Iwasa, M., Sugimoto, R., Mifuji-Moroka, R., Yoshikawa, K., Terasaka, E., Hattori, A., Ishidome, M., Kobayashi, Y., Hasegawa, H., et al. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.5676 · Cited by 113
Kaji, K., Takaya, H., Saikawa, S., Furukawa, M., Sato, S., Kawaratani, H., Kitade, M., Moriya, K., Namisaki, T., Akahane, T., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i47.8355 · Cited by 110
Liver Transplantation in the Obese Cirrhotic Patient
Spengler, E. K., O’Leary, J. G., Te, H. S., Rogal, S., Pillai, A. A., Al-Osaimi, A., Desai, A., Fleming, J. N., Ganger, D., Seetharam, A., et al. (2017) · Transplantation · doi:10.1097/tp.0000000000001794 · Cited by 102
Kawaguchi, T., Nagao, Y., Matsuoka, H., Ide, T., & Sata, M. (2008) · International Journal of Molecular Medicine · doi:10.3892/ijmm.22.1.105 · Cited by 98
Montaño‐Loza, A. J., Mazurak, V. C., Ebadi, M., Meza–Junco, J., Sawyer, M. B., Baracos, V. E., & Kneteman, N. M. (2017) · Hepatology · doi:10.1002/hep.29578 · Cited by 93
Short chain fatty acids exchange: Is the cirrhotic, dysfunctional liver still able to clear them?
Bloemen, J. G., Damink, S. W. M. O., Venema, K., Buurman, W. A., Jalan, R., & Dejong, C. H. C. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.10.002 · Cited by 92
Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation
Kamo, N., Kaido, T., Hamaguchi, Y., Okumura, S., Kobayashi, A., Shirai, H., Yao, S., Yagi, S., & Üemoto, S. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.09.019 · Cited by 90
Hjorth, M., Pourteymour, S., Görgens, S. W., Langleite, T. M., Lee, S., Holen, T., Gulseth, H. L., Birkeland, K. I., Jensen, J., Drevon, C. A., et al. (2016) · Acta Physiologica · doi:10.1111/apha.12631 · Cited by 83
Karagozian, R., Bhardwaj, G., Wakefield, D. B., & Baffy, G. (2016) · Liver International · doi:10.1111/liv.13137 · Cited by 76
Gut microbiota and physical frailty through the mediation of sarcopenia
Casati, M., Ferri, E., Azzolino, D., Cesari, M., & Arosio, B. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110639 · Cited by 75
Adiponectin: A multitasking player in the field of liver diseases
Silva, T. E., Colombo, G., & Schiavon, L. D. L. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.11.004 · Cited by 74
Bering, T., Diniz, K. G. D., Coelho, M. P. P., Vieira, D. A., Soares, M. M. S., Kakehasi, A. M., Correia, M. I. T. D., Teixeira, R., Queiroz, D. M. M., Rocha, G. A., et al. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12269 · Cited by 73
Adiponectin as an Anti-fibrotic and Anti-inflammatory Adipokine in the Liver
Park, P.-H., Sanz-Garcia, C., & Nagy, L. E. (2015) · Current Pathobiology Reports · doi:10.1007/s40139-015-0094-y · Cited by 69
Chen, C., Wang, L., Kuo, H., Fang, Y.-C., & Lee, H. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14665 · Cited by 68
Rainer, F., Horvath, A., Sandahl, T. D., Leber, B., Schmerboeck, B., Blesl, A., Groselj‐Strele, A., Stauber, R. E., Fickert, P., Stiegler, P., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14474 · Cited by 65
Kaibori, M., Ishizaki, M., Iida, H., Matsui, K., Sakaguchi, T., Inoue, K., Mizuta, T., Ide, Y., Iwasaka, J., Kimura, Y., et al. (2015) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-015-2838-8 · Cited by 64
Serum Zinc Concentration and Sarcopenia: A Close Linkage in Chronic Liver Diseases
Nishikawa, H., Enomoto, H., Yoh, K., Iwata, Y., Sakai, Y., Kishino, K., Ikeda, N., Takashima, T., Aizawa, N., Takata, R., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8030336 · Cited by 64
Self-citationShabkhiz, F., Khalafi, M., Rosenkranz, S., Karimi, P., & Moghadami, K. (2021) · European Journal of Sport Science · doi:10.1080/17461391.2020.1762755 · Cited by 64 · cited 1×
“Resistance training can reduce myostatin levels, leading to the improvement of insulin resistance [59].”
BackgroundZhao, M., Zhou, X., Yuan, C., Li, R., Ma, Y., & Tang, X. (2020) · Scientific Reports · doi:10.1038/s41598-020-73176-z · Cited by 60
Antwi, S. O., Mousa, O. Y. S., & Patel, T. C. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0010.8659 · Cited by 55
Shida, T., Oshida, N., Suzuki, H., Okada, K., Watahiki, T., Oh, S., Kim, T., Isobe, T., Okamoto, Y., Ariizumi, S., et al. (2020) · Hepatology Research · doi:10.1111/hepr.13543 · Cited by 51
Han, E., Lee, Y., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., Lee, B., Kang, E. S., Cha, B. ‐., Han, K., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14843 · Cited by 49
Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis
Nishikawa, H., Enomoto, H., Nishiguchi, S., & Iijima, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155254 · Cited by 49
Self-citationKroh, A., Uschner, D., Lodewick, T. M., Eickhoff, R., Schöning, W., Ulmer, T. F., Neumann, U. P., & Binnebösel, M. (2018) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2018.07.008 · Cited by 48
Clinical Significance of Serum Adiponectin and Resistin Levels in Liver Cirrhosis
Silva, T. E., Silva, M. C., Corrêa, C. G., Denardin, G., Alencar, M. L. A., Coelho, M. S. P. H., Wildner, L. M., Bazzo, M. L., González‐Chica, D. A., Dantas-Corrêa, E. B., et al. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0010.8660 · Cited by 47
von Hessen, L., Roumet, M., Maurer, M. H., Lange, N. F., Reeves, H. L., Dufour, J., & Radu, P. (2020) · Liver International · doi:10.1111/liv.14755 · Cited by 44
Vidot, H., Kline, K., Cheng, R., Finegan, L., Lin, A., Kempler, E., Strasser, S. I., Bowen, D. G., McCaughan, G. W., Carey, S., et al. (2019) · Nutrients · doi:10.3390/nu11092097 · Cited by 42
Serum LPS and CD163 Biomarkers Confirming the Role of Gut Dysbiosis in Overweight Patients with NASH
Hegazy, M., Mogawer, S., Alnaggar, A. R., Ghoniem, O. A., & Samie, R. M. A. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s249949 · Cited by 38
Shirai, H., Kaido, T., Hamaguchi, Y., Kobayashi, A., Okumura, S., Yao, S., Yagi, S., Kamo, N., Taura, K., Okajima, H., et al. (2017) · Liver Cancer · doi:10.1159/000484487 · Cited by 36
Çolakoğlu, Ö., Taşkıran, B., Colakoğlu, G., Kızıldağ, S., Ozcan Ari, F., & Ünsal, B. (2007) · The Turkish Journal of Gastroenterology · Cited by 35
Pijet, B., Pijet, M., Litwiniuk, A., Gajewska, M., Pająk, B., & Orzechowski, A. (2013) · Mediators of Inflammation · doi:10.1155/2013/171437 · Cited by 34
Impact of sarcopenic overweight on the outcomes after living donor liver transplantation
Hammad, A., Kaido, T., Hamaguchi, Y., Okumura, S., Kobayashi, A., Shirai, H., Kamo, N., Yagi, S., & Üemoto, S. (2017) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2017.02.02 · Cited by 32
EXERCISE PERFORMANCE AND VENTILATORY EFFICIENCY IN PATIENTS WITH MILD AND MODERATE LIVER CIRRHOSIS
Terziyski, K. V., Andonov, V. N., Marinov, B. I., & Kostianev, S. S. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04751.x · Cited by 27
Treating morbid obesity in cirrhosis: A quest of holy grail
Kumar, N., & Choudhary, N. S. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i28.2819 · Cited by 27
Effects of chronic Porphyromonas gingivalis lipopolysaccharide infusion on skeletal muscles in mice
Kawamura, N., Ohnuki, Y., Matsuo, I., Suita, K., Ishikawa, M., Mototani, Y., Shiozawa, K., Ito, A., Yagisawa, Y., Hayakawa, Y., et al. (2019) · The Journal of Physiological Sciences · doi:10.1007/s12576-019-00670-z · Cited by 26
Factors Associated With Protein-energy Malnutrition in Chronic Liver Disease
Nishikawa, H., Yoh, K., Enomoto, H., Iwata, Y., Kishino, K., Shimono, Y., Hasegawa, K., Nakano, C., Takata, R., Nishimura, T., et al. (2016) · Medicine · doi:10.1097/md.0000000000002442 · Cited by 25
Self-citationKamo, N., Kaido, T., Miyachi, Y., Iwamura, S., Yao, S., Shirai, H., Yagi, S., & Üemoto, S. (2020) · Nutrition · doi:10.1016/j.nut.2020.110798 · Cited by 17
Tang, L. V., Liu, C., Wang, X.-D., Luo, K., Zhang, D., Chi, A., Zhang, J., & Sun, L. (2014) · Biotechnology Letters · doi:10.1007/s10529-014-1617-z · Cited by 15
Sakamaki, A., Yokoyama, K., Koyama, K., Morita, S., Abé, H., Kamimura, K., Takamura, M., & Terai, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242582 · Cited by 10
Cited by
Pathophysiology and mechanisms of primary sarcopenia (Review)
Nishikawa, H., Fukunishi, S., Asai, A., Yokohama, K., Nishiguchi, S., & Higuchi, K. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4989 · Cited by 234
Self-citationCancer Cachexia: Its Mechanism and Clinical Significance
Nishikawa, H., Goto, M., Fukunishi, S., Asai, A., Nishiguchi, S., & Higuchi, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168491 · Cited by 233
Self-citationThe critical role of oxidative stress in sarcopenic obesity
Gonzalez, A., Simon, F., Achiardi, O., Vilos, C., Cabrera, D., & Cabello-Verrugio, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4493817 · Cited by 79
“As mentioned earlier, physical inactivity and obesity increase the level of lipid circulation and myosteatosis in skeletal muscle, contributing to a decrease in muscle mass and strength and favoring sarcopenia and physical disabilities [14, 22, 66].”
BackgroundAzevedo, V. Z., Silaghi, C. A., Maurel, T., Silaghi, H., Ratziu, V., & Pais, R. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.774030 · Cited by 67
Chang, J., Höfer, P., Böhling, N., Lingohr, P., Manekeller, S., Kalff, J. C., Dohmen, J., Kaczmarek, D. J., Jansen, C., Meyer, C. H., et al. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100442 · Cited by 49
Metadata
- Authors
- Nishikawa, H., Enomoto, H., Nishiguchi, S., & Iijima, H.
- Affiliations
- Hyogo Medical University (JP)
- KANO General Hospital (JP)
- Corresponding author
- Nishikawa, Hiroki
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-02-15
- Volume
- 22
- Issue
- 4
- Pages
- 1917
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7919019
- OpenAlex
- W3129491662
- Cited by
- 56
- References
- 100
- Citations by year
- 2026: 10 · 2025: 4 · 2024: 12 · 2023: 14 · 2022: 9 · 2021: 7
- FWCI
- 1.40
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- sarcopenic obesity, liver cirrhosis, sarcopenia, obesity, protein-energy malnutrition, chronic liver disease, non-alcoholic fatty liver disease, muscle mass loss, inflammatory cytokines, oxidative stress, insulin resistance, endocrine disorders, physical inactivity, pathogenesis
- MeSH terms
- Adipose Tissue, Exercise Therapy, Fasting, Humans, Insulin Resistance, Liver Cirrhosis, Obesity, Protein-Energy Malnutrition, Cytokines, Sarcopenia, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
